Cordicity is developing a software platform for advanced analysis of cardiac blood flow using contrast-enhanced cardiac CT. The company’s technology aims to improve stroke risk assessment in patients with cardiovascular disease, particularly atrial fibrillation, by enabling more individualized and data-driven clinical decision-making.

Founded in 2020, as a spin of from Linköping University and the Center of Medical Image Science and Visualization (CMIV), Cordicity is based on years of research in cardiac imaging and computational blood flow analysis. The company combines expertise in cardiology, radiology, medical imaging, and computational modeling to develop clinically integrated decision-support tools for cardiovascular care.

The company is currently in an early commercialization phase focused on clinical validation studies, regulatory preparations, and pilot collaborations with healthcare providers and strategic partners.